F new therapies for MPS. Additional improvement and validation of NRE
Chemexpress F new therapies for MPS. Additional improvement and validation of NRE biomarkers as surrogate markers are clearly warranted and could accelerate the improvement and FDA approval of new therapies.NIH-PA Author…